SAR446597
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR446597, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 1, Phase 2]